{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:26:06Z","timestamp":1740162366206,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11096-022-01460-1","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T01:38:22Z","timestamp":1658972302000},"page":"1296-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1057-2593","authenticated-orcid":false,"given":"Kebede","family":"Beyene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liandra","family":"Misquitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atifa","family":"Slaimankhel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Hai Yan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15580","author":"JT Bateman","year":"2021","unstructured":"Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid-induced respiratory depression. Br J Pharmacol. 2021. https:\/\/doi.org\/10.1111\/bph.15580.","journal-title":"Br J Pharmacol"},{"key":"1460_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/14740338.6.2.125","volume":"6","author":"EL van Dorp","year":"2007","unstructured":"van Dorp EL, Yassen A, Dahan A. Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf. 2007;6:125\u201332.","journal-title":"Expert Opin Drug Saf"},{"key":"1460_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/J354v21n01_15","volume":"21","author":"A Dahan","year":"2007","unstructured":"Dahan A. Respiratory depression with opioids. J Pain Palliat Care Pharmacother. 2007;21:63\u20136.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1460_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2217\/pmt.14.19","volume":"4","author":"F Overdyk","year":"2014","unstructured":"Overdyk F, Dahan A, Roozekrans M, et al. Opioid-induced respiratory depression in the acute care setting: a compendium of case reports. Pain Manag. 2014;4:317\u201325.","journal-title":"Pain Manag"},{"key":"1460_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/ACO.0000000000000541","volume":"31","author":"K Gupta","year":"2018","unstructured":"Gupta K, Prasad A, Nagappa M, et al. Risk factors for opioid-induced respiratory depression and failure to rescue: a review. Curr Opin Anaesthesiol. 2018;31:110\u20139.","journal-title":"Curr Opin Anaesthesiol"},{"key":"1460_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.23907\/2017.003","volume":"7","author":"D Dolinak","year":"2017","unstructured":"Dolinak D. Opioid toxicity. Acad Forensic Pathol. 2017;7:19\u201335.","journal-title":"Acad Forensic Pathol"},{"key":"1460_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024086","author":"K Gupta","year":"2018","unstructured":"Gupta K, Nagappa M, Prasad A, et al. Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses. BMJ Open. 2018. https:\/\/doi.org\/10.1136\/bmjopen-2018-024086.","journal-title":"BMJ Open"},{"key":"1460_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","volume":"112","author":"A Dahan","year":"2010","unstructured":"Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112:226\u201338.","journal-title":"Anesthesiology"},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bja.2019.05.044","volume":"123","author":"S Ayad","year":"2019","unstructured":"Ayad S, Khanna AK, Iqbal SU, et al. Characterisation and monitoring of postoperative respiratory depression: current approaches and future considerations. Br J Anaesth. 2019;123:378\u201391.","journal-title":"Br J Anaesth"},{"key":"1460_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/jpmn.2001.25012","volume":"2","author":"S Young-McCaughan","year":"2001","unstructured":"Young-McCaughan S, Miaskowski C. Definition of and mechanism for opioid-induced sedation. Pain Manag Nurs. 2001;2:84\u201397.","journal-title":"Pain Manag Nurs"},{"key":"1460_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/papr.12277","volume":"16","author":"DM Rosenfeld","year":"2016","unstructured":"Rosenfeld DM, Betcher JA, Shah RA, et al. Findings of a naloxone database and its utilization to improve safety and education in a tertiary care medical center. Pain Pract. 2016;16:327\u201333.","journal-title":"Pain Pract"},{"key":"1460_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pmn.2004.12.003","volume":"6","author":"DB Gordon","year":"2005","unstructured":"Gordon DB, Pellino TA. Incidence and characteristics of naloxone use in postoperative pain management: a critical examination of naloxone use as a potential quality measure. Pain Manag Nurs. 2005;6:30\u20136.","journal-title":"Pain Manag Nurs"},{"key":"1460_CR13","doi-asserted-by":"publisher","first-page":"e168-79","DOI":"10.1016\/j.bja.2018.12.023","volume":"122","author":"MH Algera","year":"2019","unstructured":"Algera MH, Kamp J, van der Schrier R, et al. Opioid-induced respiratory depression in humans: a review of pharmacokinetic\u2013pharmacodynamic modelling of reversal. Br J Anaesth. 2019;122:e168-79.","journal-title":"Br J Anaesth"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1213\/ANE.0000000000000792","volume":"121","author":"TN Weingarten","year":"2015","unstructured":"Weingarten TN, Herasevich V, McGlinch MC, et al. Predictors of delayed postoperative respiratory depression assessed from naloxone administration. Anesth Analg. 2015;121:422\u20139.","journal-title":"Anesth Analg"},{"key":"1460_CR15","first-page":"E827-9","volume":"18","author":"Y Khelemsky","year":"2015","unstructured":"Khelemsky Y, Kothari R, Campbell N, et al. Incidence and demographics of post-operative naloxone administration: a 13-year experience at a major tertiary teaching institution. Pain Physician. 2015;18:E827-9.","journal-title":"Pain Physician"},{"key":"1460_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2146\/ajhp130031","volume":"71","author":"HS Minkowitz","year":"2014","unstructured":"Minkowitz HS, Gruschkus SK, Shah M, et al. Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomes. Am J Health Syst Pharm. 2014;71:1556\u201365.","journal-title":"Am J Health Syst Pharm"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pmn.2018.09.009","volume":"21","author":"DR Dunwoody","year":"2020","unstructured":"Dunwoody DR, Jungquist CR. Opioid-induced sedation and respiratory depression: are sedation scales enough to prevent adverse drug events postoperatively? Pain Manag Nurs. 2020;21:110\u20139.","journal-title":"Pain Manag Nurs"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2146\/ajhp160208","volume":"74","author":"B Meisenberg","year":"2017","unstructured":"Meisenberg B, Ness J, Rao S, et al. Implementation of solutions to reduce opioid-induced oversedation and respiratory depression. Am J Health Syst Pharm. 2017;74:162\u20139.","journal-title":"Am J Health Syst Pharm"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2146\/ajhp130568","volume":"71","author":"J Pawasauskas","year":"2014","unstructured":"Pawasauskas J, Stevens B, Youssef R, et al. Predictors of naloxone use for respiratory depression and oversedation in hospitalized adults. Am J Health Syst Pharm. 2014;71:746\u201350.","journal-title":"Am J Health Syst Pharm"},{"key":"1460_CR20","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2146\/ajhp170558","volume":"75","author":"JM Brant","year":"2018","unstructured":"Brant JM, Stringer L, Jurkovich LR, et al. Predictors of oversedation in hospitalized patients. Am J Health Syst Pharm. 2018;75:1378\u201385.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"1460_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/emj.20.1.54","volume":"20","author":"C Mann","year":"2003","unstructured":"Mann C. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54\u201360.","journal-title":"Emerg Med J"},{"issue":"12","key":"1460_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1460_CR23","first-page":"710","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007 Am J Epidemiol. 2007;165(6):710\u20138.","journal-title":"Am J Epidemiol 2007 Am J Epidemiol"},{"key":"1460_CR24","volume-title":"NZDep2013 index of deprivation","author":"J Atkinson","year":"2014","unstructured":"Atkinson J, Salmond C, Crampton P. NZDep2013 index of deprivation. Wellington: Department of Public Health, University of Otago; 2014."},{"issue":"6","key":"1460_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3945","volume":"25","author":"S Nielsen","year":"2016","unstructured":"Nielsen S, Degenhardt L, Hoban B, et al. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf. 2016;25(6):733\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1460_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i969","author":"N Pearce","year":"2016","unstructured":"Pearce N. Analysis of matched case-control studies. BMJ. 2016. https:\/\/doi.org\/10.1136\/bmj.i969.","journal-title":"BMJ"},{"key":"1460_CR27","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.2105\/AJPH.81.12.1630","volume":"81","author":"DW Hosmer","year":"1991","unstructured":"Hosmer DW, Taber S, Lemeshow S. The importance of assessing the fit of logistic regression models: a case study. Am J Public Health. 1991;81:1630\u20135.","journal-title":"Am J Public Health"},{"key":"1460_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/jcpt.12701","volume":"43","author":"Q Vu","year":"2018","unstructured":"Vu Q, Beselman A, Monolakis J, et al. Risk factors for opioid overdose among hospitalized patients. J Clin Pharm Ther. 2018;43:784\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"1460_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/00325481.2017.1263139","volume":"129","author":"L Yung","year":"2017","unstructured":"Yung L, Lee KC, Hsu C, et al. Patterns of naloxone use in hospitalized patients. Postgrad Med. 2017;129:40\u20135.","journal-title":"Postgrad Med"},{"key":"1460_CR30","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1111\/pme.12480","volume":"15","author":"B Zedler","year":"2014","unstructured":"Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014;15:1911\u201329.","journal-title":"Pain Med"},{"key":"1460_CR31","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1056\/NEJMra1807054","volume":"380","author":"KM Babu","year":"2019","unstructured":"Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019;380:2246\u201355.","journal-title":"N Engl J Med"},{"key":"1460_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA. 2016;315:1624\u201345.","journal-title":"JAMA"},{"key":"1460_CR33","doi-asserted-by":"publisher","first-page":"118,145","DOI":"10.1016\/j.pmn.2011.06.008","volume":"12","author":"D Jarzyna","year":"2011","unstructured":"Jarzyna D, Jungquist CR, Pasero C, et al. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression. Pain Manag Nurs. 2011;12:118,145. e10.","journal-title":"Pain Manag Nurs"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-022-01460-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T20:03:35Z","timestamp":1670097815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-022-01460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s11096-022-01460-1","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KB reports grants from Health Research Council of New Zealand, Amgen, A\u2009+\u2009Charitable Trust (Auckland District Health Board), Universitas 21, New Zealand Pharmacy Education and Research Foundation, the University of Auckland, and Addis Ababa University outside this work. AC is a fellow and supported by Asthma UK as part of the Asthma UK Centre for Applied Research (Grant Nos. AUK-AC-2012-01 and AUK-AC-2018-01). AC reports grants from Innovate UK, A\u2009+\u2009CharitableTrust (Auckland District Health Board), Maurice and Phyllis Paykel Trust, Universitas 21, New Zealand Pharmacy Education Research Fund, Auckland Academic Health Alliance, AsthmaUK, Health Research Council, Chorus Ltd, Oakley Mental Health Foundation and the University of Auckland; reports consultancy fees from Janssen-Cilag and UCL-Business spin-out company Spoonful of Sugar Ltd; and is the recipient of the Robert Irwin Postdoctoral Fellowship, outside the submitted work. All other authors report no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}